Banked Human Milk and Quantitative Risk Assessment of


Journal

The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale
ISSN: 1712-9532
Titre abrégé: Can J Infect Dis Med Microbiol
Pays: Egypt
ID NLM: 101226876

Informations de publication

Date de publication:
2019
Historique:
received: 05 10 2018
accepted: 31 12 2018
entrez: 14 3 2019
pubmed: 14 3 2019
medline: 14 3 2019
Statut: epublish

Résumé

Banked human milk (BHM) offers potential health benefits to premature babies. BHM is pasteurized to mitigate infectious risks, but pasteurization is ineffective against sporulating bacteria such as Our aim was to estimate the potential risk of In the absence of scientific evidence regarding the risk of The mean risk differential between the two methods of post-pasteurization bacteriological control for realistic infectious doses of 30 to 200 CFU/ml ranges from 0.036 to 0.0054, 0.47 to 0.070, and 0.72 to 0.11 per million servings, for each of the three scenarios. Simulation highlights the very small risk of

Sections du résumé

BACKGROUND BACKGROUND
Banked human milk (BHM) offers potential health benefits to premature babies. BHM is pasteurized to mitigate infectious risks, but pasteurization is ineffective against sporulating bacteria such as
OBJECTIVE OBJECTIVE
Our aim was to estimate the potential risk of
METHODS METHODS
In the absence of scientific evidence regarding the risk of
RESULTS RESULTS
The mean risk differential between the two methods of post-pasteurization bacteriological control for realistic infectious doses of 30 to 200 CFU/ml ranges from 0.036 to 0.0054, 0.47 to 0.070, and 0.72 to 0.11 per million servings, for each of the three scenarios.
CONCLUSION CONCLUSIONS
Simulation highlights the very small risk of

Identifiants

pubmed: 30863469
doi: 10.1155/2019/6348281
pmc: PMC6378033
doi:

Types de publication

Journal Article

Langues

eng

Pagination

6348281

Références

Pediatrics. 1999 Jun;103(6 Pt 1):1150-7
pubmed: 10353922
Int J Food Microbiol. 2000 Jul 15;58(3):181-96
pubmed: 10939268
J Clin Microbiol. 2000 Nov;38(11):4131-6
pubmed: 11060080
J Hum Lact. 2002 Nov;18(4):361-7
pubmed: 12449052
J Clin Microbiol. 2003 Jul;41(7):3441-4
pubmed: 12843116
J Pediatr Gastroenterol Nutr. 2003 Oct;37(4):437-46
pubmed: 14508214
Lancet. 2004 May 15;363(9421):1571-8
pubmed: 15145629
Pediatrics. 2005 Feb;115(2):496-506
pubmed: 15687461
Int J Food Microbiol. 2005 Apr 15;100(1-3):311-22
pubmed: 15854714
Pediatrics. 2006 Jul;118(1):e115-23
pubmed: 16818526
J Perinatol. 2007 Jul;27(7):428-33
pubmed: 17443195
Biosecur Bioterror. 2008 Jun;6(2):147-60
pubmed: 18582166
Am J Infect Control. 2010 Mar;38(2):144-8
pubmed: 19822381
J Perinat Med. 2010 May;38(3):233-8
pubmed: 20184400
Clin Microbiol Rev. 2010 Apr;23(2):382-98
pubmed: 20375358
Breastfeed Med. 2010 Jun;5(3):117-21
pubmed: 20509779
Am J Infect Control. 2013 Oct;41(10):918-21
pubmed: 23769834
Am J Infect Control. 2014 Jun;42(6):694-5
pubmed: 24725514
Environ Sci Technol. 2015 Feb 3;49(3):1245-59
pubmed: 25545032
Arch Pediatr. 2015 May;22(5):461-7
pubmed: 25858450
Health Econ Rev. 2016 Dec;6(1):54
pubmed: 27909996
Early Hum Dev. 2017 Feb;105:1-6
pubmed: 28088062
Emerg Infect Dis. 2017 May;23(5):845-848
pubmed: 28418291
Am J Epidemiol. 1983 Oct;118(4):573-82
pubmed: 6637984

Auteurs

Antoine Lewin (A)

Medical Affairs and Innovation, Héma-Québec, Montreal, QC, Canada.
Department of Obstetrics and Gynecology, University of Sherbrooke, Sherbrooke, QC, Canada.

Gilles Delage (G)

Medical Affairs and Innovation, Héma-Québec, Montreal, QC, Canada.

France Bernier (F)

Quality and Regulatory Affairs, Héma-Québec, Montreal, QC, Canada.

Marc Germain (M)

Medical Affairs and Innovation, Héma-Québec, Québec, QC, Canada.

Classifications MeSH